Modified streptozotocin-induced diabetic model in rodents
作者机构:Department of OphthalmologySchepens Eye Research InstituteMass Eye and EarHarvard Medical SchoolBostonMassachusettsUSA
出 版 物:《Animal Models and Experimental Medicine》 (动物模型与实验医学(英文))
年 卷 期:2024年第7卷第5期
页 面:777-780页
核心收录:
学科分类:1002[医学-临床医学] 100201[医学-内科学(含:心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学]
基 金:Schepens Eye Research Institute of Massachusetts Eye and Ear Department of Ophthalmology Massachusetts Lions Charitable Foundation U.S. Department of Defense, DOD, (HT9425‐23‐1‐1045) U.S. Department of Defense, DOD
主 题:hyperglycemia non- fasting streptozotocin Type 1 diabetes mellitus
摘 要:Streptozotocin(STZ)-induced type I diabetes mellitus(DM)models have been pivotal in diabetes research due to their ability to mimic the insulin-dependent hyperglyce-mia akin to human type I ***,these models often suffer from poor induction rates and low survival post-STZ induction,especially in long-term experi-ments,necessitating insulin supplementation,which introduces additional variables to *** address this,we present a novel modification to the STZ-induced DM model in C57BL/6J mice to improve survival rates without insulin *** method involves non-fasting,low-dose STZ injections dissolved in pH-neutral phosphate buffer saline instead of acidic sodium citrate buffer,administered over 5 *** observed hyperglycemia induction in 94.28%of mice within a week post-injection,with stable high blood glucose levels,stable body weight,and minimal mortality up to 21 ***,omitting 10%sucrose in water and fasting did not affect hyperglycemia *** findings suggest that the modified protocol not only decreases the experimental effort of the researchers,but reduces animal stress and mortality,thus enhancing experimental outcomes and animal *** opti-mizing the STZ-induced DM model in C57BL/6J mice,our study provides a valuable resource for researchers aiming to study diabetes and its complications while mini-mizing experimental variability and animal usage.